Rothschild & Co Asset Management US’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $100M | Sell |
274,285
-41,158
| -13% | -$14.6M | 1.53% | 22 |
|
|
2022
Q3 | $102M | Sell |
315,443
-23,213
| -7% | -$7.35M | 1.74% | 11 |
|
|
2022
Q2 | $110M | Sell |
338,656
-43,717
| -11% | -$13.1M | 1.69% | 12 |
|
|
2022
Q1 | $110M | Buy |
382,373
+11,918
| +3% | +$3.07M | 1.4% | 20 |
|
|
2021
Q4 | $102M | Sell |
370,455
-7,562
| -2% | -$1.92M | 1.2% | 25 |
|
|
2021
Q3 | $87.3M | Sell |
378,017
-13,407
| -3% | -$3.31M | 1.08% | 31 |
|
|
2021
Q2 | $89.8M | Buy |
391,424
+13,615
| +4% | +$2.73M | 1.07% | 31 |
|
|
2021
Q1 | $70.6M | Buy |
377,809
+9,978
| +3% | +$1.95M | 0.87% | 38 |
|
|
2020
Q4 | $62.1M | Buy |
367,831
+165,207
| +82% | +$24.7M | 0.8% | 40 |
|
|
2020
Q3 | $30M | Sell |
202,624
-140,322
| -41% | -$21.7M | 0.54% | 54 |
|
|
2020
Q2 | $56.3M | Sell |
342,946
-34,299
| -9% | -$5.26M | 0.83% | 17 |
|
|
2020
Q1 | $52.3M | Sell |
377,245
-51,901
| -12% | -$7.13M | 0.82% | 22 |
|
|
2019
Q4 | $56.4M | Sell |
429,146
-4,717
| -1% | -$547K | 0.59% | 37 |
|
|
2019
Q3 | $48.5M | Sell |
433,863
-10,188
| -2% | -$1.13M | 0.52% | 43 |
|
|
2019
Q2 | $49.2M | Sell |
444,051
-11,148
| -2% | -$1.31M | 0.52% | 43 |
|
|
2019
Q1 | $59.1M | Sell |
455,199
-124,718
| -22% | -$15.2M | 0.63% | 32 |
|
|
2018
Q4 | $67.1M | Buy |
579,917
+94,037
| +19% | +$10.5M | 0.81% | 15 |
|
|
2018
Q3 | $52.1M | Sell |
485,880
-47,471
| -9% | -$4.75M | 0.53% | 50 |
|
|
2018
Q2 | $45.5M | Sell |
533,351
-4,643
| -0.9% | -$381K | 0.49% | 53 |
|
|
2018
Q1 | $41.6M | Sell |
537,994
-29,777
| -5% | -$2.4M | 0.46% | 61 |
|
|
2017
Q4 | $48M | Sell |
567,771
-26,734
| -4% | -$2.27M | 0.51% | 59 |
|
|
2017
Q3 | $50.9M | Sell |
594,505
-174,495
| -23% | -$14.3M | 0.56% | 44 |
|
|
2017
Q2 | $63.3M | Sell |
769,000
-114,359
| -13% | -$9.33M | 0.71% | 30 |
|
|
2017
Q1 | $74.3M | Buy |
883,359
+35,136
| +4% | +$2.81M | 0.85% | 17 |
|
|
2016
Q4 | $62.4M | Buy |
848,223
+831,774
| +5,057% | +$61.9M | 0.79% | 25 |
|
|
2016
Q3 | $1.32M | Buy |
16,449
+1,584
| +11% | +$127K | 0.02% | 336 |
|
|
2016
Q2 | $1.17M | Buy |
14,865
+636
| +4% | +$47.9K | 0.02% | 350 |
|
|
2016
Q1 | $1.02M | Buy |
14,229
+5,343
| +60% | +$404K | 0.02% | 314 |
|
|
2015
Q4 | $749K | Buy |
8,886
+2,292
| +35% | +$190K | 0.01% | 333 |
|
|
2015
Q3 | $552K | Sell |
6,594
-575
| -8% | -$48.5K | 0.01% | 331 |
|
|
2015
Q2 | $599K | Sell |
7,169
-6,964
| -49% | -$531K | 0.01% | 326 |
|
|
2015
Q1 | $1.03M | Buy |
14,133
+1,018
| +8% | +$72.5K | 0.02% | 323 |
|
|
2014
Q4 | $905K | Hold |
13,115
| – | – | 0.02% | 337 |
|
|
2014
Q3 | $851K | Sell |
13,115
-1,080
| -8% | -$68.4K | 0.02% | 336 |
|
|
2014
Q2 | $883K | Sell |
14,195
-220
| -2% | -$13.1K | 0.02% | 340 |
|
|
2014
Q1 | $848K | Buy |
14,415
+2,479
| +21% | +$138K | 0.02% | 352 |
|
|
2013
Q4 | $609K | Sell |
11,936
-121
| -1% | -$6.06K | 0.01% | 358 |
|
|
2013
Q3 | $607K | Sell |
12,057
-220
| -2% | -$11.5K | 0.01% | 354 |
|
|
2013
Q2 | $603K | Buy |
+12,277
| New | +$668K | 0.01% | 355 |
|
Other funds holding LLY
Rothschild & Co Asset Management US's LLY Position: Q4 2022 in Review
Rothschild & Co Asset Management US reduced its Eli Lilly (LLY) stake by 13% in Q4 2022, selling an estimated $14.6M and leaving 274,285 shares worth $100M. The position accounts for 1.53% of the portfolio, ranked #22.
Rothschild & Co Asset Management US first reported a position in LLY in Q2 2013 and has held it in 39 quarters since. The position peaked at $110M in Q2 2022. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Rothschild & Co Asset Management US held 274,285 shares of Eli Lilly worth $100M as of Q4 2022.
- Rothschild & Co Asset Management US sold 41,158 Eli Lilly shares in Q4 2022, an estimated $14.6M.
- Eli Lilly made up 1.53% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #22 holding.
- Rothschild & Co Asset Management US first reported a position in Eli Lilly in Q2 2013 and has held it in 39 quarters since.
- Rothschild & Co Asset Management US's Eli Lilly position peaked at $110M in Q2 2022.
- 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.